中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

4 records (took 0.015 seconds)

    LED lamp
    1.
    发明授权
    LED lamp 失效
    点灯

    公开(公告)号：US08388172B2

    公开(公告)日：2013-03-05

    申请号：US13070487

    申请日：2011-03-24

    Applicant: Jun Yue ,  Huai-Shan Gu ,  Ting Dong ,  Fu-Bo Gong

    Inventor： Jun Yue ,  Huai-Shan Gu ,  Ting Dong ,  Fu-Bo Gong

    IPC: F21S4/00

    CPC classification number: F21V19/0045 ,  F21K9/272 ,  F21V29/70 ,  F21V29/89 ,  F21Y2103/10 ,  F21Y2115/10

    Abstract: An LED lamp includes a cylindrical tube and two lamp holders fixed on two ends of the cylindrical tube. The cylindrical tube comprises a lampshade, a lamp plate, and a heat dispersing plate. The heat dispersing plate further comprises a base portion and two fastening portions. Two free edges of the base portion comprise two supports extending toward each other. The fastening portions are connected to the supports correspondingly, and the lamp shape and the lamp plate are fixed to the fastening portions correspondingly. Two lamp holders are fixed to opposite ends of the cylindrical tube, and each of the lamp holders comprises a hollow shell and a protrusion formed on an inner wall of the hollow shell. The protrusion resists against one end of the supports to prevent the lampshade from rotating relative to the heat dispersing plate.

    Abstract translation: LED灯包括圆柱形管和固定在圆柱形管的两端上的两个灯座。 圆柱形管包括灯罩，灯板和散热板。 散热板还包括基部和两个紧固部。 基部的两个自由边缘包括两个朝向彼此延伸的支撑件。 紧固部相应地连接到支撑件，并且灯形状和灯板相应地固定到紧固部分。 两个灯座固定在圆柱形管的相对端，每个灯座包括中空壳和形成在中空壳的内壁上的突起。 突起抵抗支撑件的一端以防止灯罩相对于散热板旋转。

    Cable receiving apparatus and lamp using the same
    2.
    发明授权
    Cable receiving apparatus and lamp using the same 失效
    电缆接收装置及使用其的灯

    公开(公告)号：US08454210B2

    公开(公告)日：2013-06-04

    申请号：US13114031

    申请日：2011-05-23

    Applicant: Huai-Shan Gu ,  Jun Yue

    Inventor： Huai-Shan Gu ,  Jun Yue

    IPC: F21V21/00 ,  F21S8/08

    CPC classification number: F21S6/005 ,  F21V21/06 ,  F21V21/32 ,  F21V23/002 ,  F21V23/003

    Abstract: A cable receiving apparatus include a hollow base defining a through hole, a hollow conduit including a threaded end. The threaded end passes through the through hole and engages a nut to connect the hollow conduit to the hollow base. The threaded end defines a first slot for a cable running through the hollow conduit to enter the hollow base. In this way, during the assembly process, operators can assemble the cable first, then use a socket wrench to screw the nut directly.

    Abstract translation: 电缆接收装置包括限定通孔的中空基座，包括螺纹端部的中空导管。 螺纹端穿过通孔并与螺母接合，以将中空导管连接到空心基座。 螺纹端部限定用于穿过中空管道的电缆的第一槽，以进入空心基座。 这样，在组装过程中，操作人员可以首先组装电缆，然后使用套筒扳手直接拧紧螺母。

    METHOD OF SCREENING DRUG-RESISTANCE PROTEIN OF MYCOBACTERIUM TUBERCULOSIS
    3.
    发明申请
    METHOD OF SCREENING DRUG-RESISTANCE PROTEIN OF MYCOBACTERIUM TUBERCULOSIS 审中-公开

    公开(公告)号：US20080187922A1

    公开(公告)日：2008-08-07

    申请号：US11871932

    申请日：2007-10-12

    Applicant: Honghai Wang ,  Lu Zhang ,  Qingzhong Wang ,  Jun Yue ,  Min Zhang ,  Ying Xu ,  Bingdong Zhu ,  Jiuling Wang ,  Yaqing Qie

    Inventor： Honghai Wang ,  Lu Zhang ,  Qingzhong Wang ,  Jun Yue ,  Min Zhang ,  Ying Xu ,  Bingdong Zhu ,  Jiuling Wang ,  Yaqing Qie

    IPC: C12Q1/68

    CPC classification number: C12Q1/689 ,  C12Q1/18 ,  C12Q2600/156 ,  G01N33/5695 ,  G01N2333/35 ,  G01N2500/00

    Abstract: The present invention belongs to the field of molecular biology. Specially, the invention relates to the screenings of a new drug target, a vaccine antigen and a test target of anti-tuberculosis treatment. Specially, based on the differential proteome technology and by the techniques of gene sequencing, in vitro protein expression, immunological detection and gene recombination, the invention primarily certifies that the up-regulated expression of Protein Rv2629 and the mutation of Gene 191A/C of Mycobacterium tuberculosis are related to the Rifampicin (RFP) drug-resistance, which provides useful information for the drug-resistance detection of Mycobacterium tuberculosis, the novel drug design and the vaccine development. Firstly, the drug-resistant strains are cultured and the proteins from drug resistance strains and sensitive strains are isolated respectively. Secondly, the proteins from the drug resistance strains and the sensitive strains are compared to determine the differential protein sites, such that the drug-resistant proteins are identified by means of Mass Spectrometry. Next, the up-regulated expression of Protein Rv2629 and the mutation of gene are correlated to the drug-resistance of Mycobacterium tuberculosis by means of gene sequencing technique. Finally, after the gene cloning, the in vitro expression and purification of the protein, the wild-type and mutant-type recombinant protein of Rv2629 are obtained. The polyclonal antibody is prepared, and the protein subcellular localization is carried out. The Minimum Inhibitory Concentrations (MICs) of the strains containing different plasmids obtained by the transformation of recombinant shuttle plasmids are also measured. The gene encoding the protein Rv2629 in the genome of Mycobacterium tuberculosis is isolated and is up-regulation expressed in a Rifampicin (RFP)-resistant strains. And the A/C gene mutation at nucleotide 191 which is related to drug-resistance is detected. The relationship between the mutation and the Rifampicin (RFP)-resistance is primarily certified by molecular biology technique and the in vitro experiments. This invention provides methods used to accurately isolate and identify the drug-resistance protein of Mycobacterium tuberculosis. The A/C mutation of Rv2629 at nucleotide 191 related to the drug-resistance of Mycobacterium tuberculosis is isolated, which shows new approach for the further study of Mycobacterium tuberculosis drug-resistant mechanism, the rapid detection of clinical drug-resistance strains, as well as the developments of new drug targets and vaccines.

Patent Agency Ranking